Control of HIV-1 replication by RNA interference

Virus Research

Volumn 102, Issue 1, 2004, Pages 53-58

  Lee, Nan Sook ^a   Rossi, John J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

HIV 1; PTGS; RNAi; shRNA; siRNA

Indexed keywords

ANTIVIRUS AGENT; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; GENOMIC RNA; LENTIVIRUS VECTOR; SMALL INTERFERING RNA;

DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG TARGETING; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MOLECULAR MECHANICS; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; RNA DEGRADATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VIROGENESIS; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA;

EID: 1842478962     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2004.01.015     Document Type: Article

References (48)

1. Abbas-Terki T., Blanco-Bose W., Deglon N., Pralong W., Aebischer P. Lentiviral-mediated RNA interference. Hum. Gene. Ther. 13:2002;2197-2201.
2. Agami R. RNAi and related mechanisms and their potential use for therapy. Curr. Opin. Chem. Biol. 6:2002;829-834.
3. Banerjea A., Li M.J., Bauer G., Remling L., Lee N.S., Rossi J., Akkina R. Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages. Mol. Ther. 8:2003;62-71.
4. Bernstein E., Caudy A.A., Hammond S.M., Hannon G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature. 409:2001;363-366.
5. Bridge A.J., Pebernard S., Ducraux A., Nicoulaz A.L., Iggo R. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34:2003;263-264.
6. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296:2002;550-553.
7. Capodici J., Kariko K., Weissman D. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J. Immunol. 169:2002;5196-5201.
8. Coburn G.A., Cullen B.R. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J. Virol. 76:2002;9225-9231.
9. Cottrell T.R., Doering T.L. Silence of the strands: RNA interference in eukaryotic pathogens. Trends Microbiol. 11:2003;37-43.
10. Elbashir S.M., Lendeckel W., Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15:2001;188-200.
11. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391:1998;806-811.
12. Gitlin L., Karelsky S., Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature. 418:2002;430-434.
13. Greene W.C., Peterlin B.M. Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy. Nat. Med. 8:2002;673-680.
14. Hammond S.M., Boettcher S., Caudy A.A., Kobayashi R., Hannon G.J. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science. 293:2001;1146-1150.
15. Hu W., Myers C., Kilzer J., Pfaff S., Bushman F. Inhibition of retroviral pathogenesis by RNA interference. Curr. Biol. 12:2002a;1301.
16. Hu W.Y., Myers C.P., Kilzer J.M., Pfaff S.L., Bushman F.D. Inhibition of retroviral pathogenesis by RNA interference. Curr. Biol. 12:2002b;1301-1311.
17. Hutvagner G., McLachlan J., Pasquinelli A.E., Balint E., Tuschl T., Zamore P.D. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science. 293:2001;834-838.
18. Hutvagner G., Zamore P.D. RNAi: nature abhors a double-strand. Curr. Opin. Genet. Dev. 12:2002;225-232.
19. Jacque J.M., Triques K., Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature. 418:2002;435-438.
20. Ketting R.F., Fischer S.E., Bernstein E., Sijen T., Hannon G.J., Plasterk R.H. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev. 15:2001;2654-2659.
21. Kitabwalla M., Ruprecht R.M. RNA interference - a new weapon against HIV and beyond. N. Engl. J. Med. 347:2002;1364-1367.
22. Knight S.W., Bass B.L. A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans. Science. 293:2001;2269-2271.
23. Lee N.S., Dohjima T., Bauer G., Li H., Li M.J., Ehsani A., Salvaterra P., Rossi J. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20:2002a;500-505.
24. Lee Y., Jeon K., Lee J.T., Kim S., Kim V.N. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21:2002b;4663-4670.
25. Martinez M.A., Gutierrez A., Armand-Ugon M., Blanco J., Parera M., Gomez J., Clotet B., Este J.A. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS. 16:2002;2385-2390.
26. Matta H., Hozayev B., Tomar R., Chugh P., Chaudhary P.M. Use of lentiviral vectors for delivery of small interfering RNA. Cancer Biol. Ther. 2:2003;206-210.
27. Miyagishi M., Taira K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol. 20:2002;497-500.
28. Novina C.D., Murray M.F., Dykxhoorn D.M., Beresford P.J., Riess J., Lee S.K., Collman R.G., Lieberman J., Shankar P., Sharp P.A. siRNA-directed inhibition of HIV-1 infection. Nat. Med. 8:2002;681-686.
29. Paddison P.J., Caudy A.A., Bernstein E., Hannon G.J., Conklin D.S. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16:2002a;948-958.
30. Paddison P.J., Caudy A.A., Hannon G.J. Stable suppression of gene expression by RNAi in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 99:2002b;1443-1448.
31. Paddison P.J., Hannon G.J. RNA interference: the new somatic cell genetics. Cancer Cell. 2:2002;17-23.
32. Parrish S., Fleenor J., Xu S., Mello C., Fire A. Functional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interference. Mol. Cell. 6:2000;1077-1087.
33. Paul C.P., Good P.D., Winer I., Engelke D.R. Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20:2002;505-508.
34. Qin X.F., An D.S., Chen I.S., Baltimore D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. U.S.A. 100:2003;183-188.
35. Rubinson D.A., Dillon C.P., Kwiatkowski A.V., Sievers C., Yang L., Kopinja J., Rooney D.L., Ihrig M.M., McManus M.T., Gertler F.B., Scott M.L., Van Parijs L. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33:2003;401-406.
36. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.M., Saragosti S., Lapoumeroulie C., Cognaux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R.J., Collman R.G., Doms R.W., Vassart G., Parmentier M. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 382:1996;722-725.
37. Scherr M., Morgan M.A., Eder M. Gene silencing mediated by small interfering RNAs in mammalian cells. Curr. Med. Chem. 10:2003;245-256.
38. Sharp P.A. RNA interference - 2001. Genes Dev. 15:2001;485-490.
39. Song E., Lee S.K., Dykxhoorn D.M., Novina C., Zhang D., Crawford K., Cerny J., Sharp P.A., Lieberman J., Manjunath N., Shankar P. Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages. J. Virol. 77:2003;7174-7181.
40. Stojdl D.F., Lichty B., Knowles S., Marius R., Atkins H., Sonenberg N., Bell J.C. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat. Med. 6:2000;821-825.
41. Sui G., Soohoo C., Affar el B., Gay F., Shi Y., Forrester W.C. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 99:2002;5515-5520.
42. Tiscornia G., Singer O., Ikawa M., Verma I.M. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl. Acad. Sci. U.S.A. 100:2003;1844-1848.
43. Waterhouse P.M., Wang M.B., Lough T. Gene silencing as an adaptive defence against viruses. Nature. 411:2001;834-842.
44. Xia H., Mao Q., Paulson H.L., Davidson B.L. siRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol. 20:2002;1006-1010.
45. Yu J.Y., DeRuiter S.L., Turner D.L. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 99:2002;6047-6052.
46. Zamore P.D., Tuschl T., Sharp P.A., Bartel D.P. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell. 101:2000;25-33.
47. Zeng Y., Cullen B.R. RNA interference in human cells is restricted to the cytoplasm. RNA. 8:2002;855-860.
48. Zeng Y., Wagner E.J., Cullen B.R. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol. Cell. 9:2002;1327-1333.